Key Insights Significantly high institutional ownership implies Compass Therapeutics’ stock price is sensitive to …
Institutional investors in Compass Therapeutics, Inc. (NASDAQ:CMPX) lost 9.0% last week but have reaped the benefits of longer-term growth
view original post